Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

14.39

-0.01 (-0.07%)

At close: Mar 9, 2026, 4:00 PM EDT

14.11

-0.28 (-1.95%)

After-hours: Mar 9, 2026, 5:00 PM EDT

Dr. Reddy's Laboratories Market Cap

Dr. Reddy's Laboratories has a market cap or net worth of $11.63 billion as of March 9, 2026. Its market cap has increased by 3.71% in one year.

Market Cap

11.63B

Enterprise Value

11.50B

1-Year Change

3.71%

Ranking

#839

Market Cap Chart

Since April 11, 2001, Dr. Reddy's Laboratories's market cap has increased from $839.80M to $11.63B, an increase of 1,284.34%. That is a compound annual growth rate of 11.12%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	12.02B	2.56%
Dec 31, 2025	11.72B	-11.04%
Dec 31, 2024	13.17B	13.66%
Dec 29, 2023	11.59B	34.54%
Dec 30, 2022	8.61B	-20.82%
Dec 31, 2021	10.88B	-8.18%
Dec 31, 2020	11.85B	75.79%
Dec 31, 2019	6.74B	7.74%
Dec 31, 2018	6.25B	0.47%
Dec 29, 2017	6.23B	-19.41%
Dec 30, 2016	7.73B	-2.05%
Dec 31, 2015	7.89B	-8.10%
Dec 31, 2014	8.58B	23.16%
Dec 31, 2013	6.97B	23.45%
Dec 31, 2012	5.64B	13.32%
Dec 30, 2011	4.98B	-20.18%
Dec 31, 2010	6.24B	53.01%
Dec 31, 2009	4.08B	147.47%
Dec 31, 2008	1.65B	-45.95%
Dec 31, 2007	3.05B	9.23%
Dec 29, 2006	2.79B	68.91%
Dec 30, 2005	1.65B	8.92%
Dec 31, 2004	1.52B	-37.34%
Dec 31, 2003	2.42B	50.67%
Dec 31, 2002	1.61B	2.01%

View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	36.16B
United Therapeutics	20.96B
Viatris	16.30B
Neurocrine Biosciences	12.86B
Elanco Animal Health	11.61B
Regencell Bioscience Holdings	11.55B
Alkermes	4.77B
Lantheus Holdings	4.69B

Market Cap Rankings